Nano‐Optical Biomolecular Interaction Sensing Within Complex Media via Peptide Hybrid Ligand Conjugation
Small · 04.11.2026
DOI: 10.1002/smll.75794 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 04.11.2026. Verfasst von Gurunath Apte und 10 weiteren Autor:innen. Beteiligte Einrichtung: Helmholtz Pioneer Campus, Helmholtz Munich, Neuherberg, Germany. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Protein–protein interactions (PPIs) govern most biological processes and are frequently altered in disease. However, in vitro characterization methods are often limited to binding affinities, specialized instrumentation, or are susceptible to extended‐surface artifacts. Moreover, many remain incompatible with physiological media. Nano‐optical biosensing based on nanoparticle (NP) localized surface plasmon resonances (LSPRs) offers an attractive in‐solution alternative, but their performance has been limited in complex environments. Here, we present a solution‐phase optical platform based on plasmonic nanoparticles functionalized with programmable peptide‐hybrid ligands. We use sequence‐defined ligands that combine nanoparticle anchoring, suppression of non‐specific interactions, and site‐specific bioconjugation. Unlike conventional polymers, these ligands are molecularly precise via solid‐phase peptide synthesis. We show how this architecture effectively suppresses nonspecific adsorption while preserving colloidal stability and optical performance, and can be adapted to diverse protein targets through click chemistry and Sortase‐mediated ligation. This platform enables high‐sensitivity, label‐free PPI detection via standard UV–vis spectrophotometry and minimal sample amounts. We quantify binding affinities of low molecular‐weight proteins directly in undiluted serum, along with kinetic profiling in buffer. Furthermore, we demonstrate applicability over multiple protein pairs in buffer and serum, as well as proof‐of‐concept detection and quantification in human serum, highlighting its potential for future diagnostic applications.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Helmholtz Pioneer Campus, Helmholtz Munich, Neuherberg, Germany.
- Photonic Biosystems and Technologies, Bioengineering Center, Helmholtz Munich, Neuherberg, Germany.
- Institute of Medicinal Chemistry, Molecular Targets and Therapeutics Center, Helmholtz Munich, Neuherberg, Germany.
- Institute of Organic Chemistry, Leibniz University Hannover, Hannover, Germany.
- Department of Bioscience, TUM School of Natural Sciences, Physics Department and Center of Protein Assemblies, Technical University of Munich, Garching, Germany.
- Institute of Structural Biology, Molecular Targets and Therapeutics Center, Helmholtz Munich, Neuherberg, Germany.
ORCID-Profile: Gurunath Apte, Moritz Roman Schepp, Niklas Halbwedl, Na Sun, Axel Walch, Martin Zacharias, Michael Sattler, Oliver Plettenburg, Jian Cui
Zitieren
APA
Apte, G., Schepp, M. R., Ball, H. L., Halbwedl, N., Zou, P., Sun, N., Walch, A., Zacharias, M., Sattler, M., Plettenburg, O., & Cui, J. (2026). Nano‐Optical Biomolecular Interaction Sensing Within Complex Media via Peptide Hybrid Ligand Conjugation. Small. https://doi.org/10.1002/smll.75794
Vancouver
Apte G, Schepp MR, Ball HL, Halbwedl N, Zou P, Sun N, et al. Nano‐Optical Biomolecular Interaction Sensing Within Complex Media via Peptide Hybrid Ligand Conjugation. Small. 2026. doi:10.1002/smll.75794
BibTeX
@article{Apte2026,
author = {Apte, Gurunath and Schepp, Moritz Roman and Ball, Haydn L and Halbwedl, Niklas and Zou, Peijian and Sun, Na and Walch, Axel and Zacharias, Martin and Sattler, Michael and Plettenburg, Oliver and Cui, Jian},
title = {Nano‐Optical Biomolecular Interaction Sensing Within Complex Media via Peptide Hybrid Ligand Conjugation},
journal = {Small},
year = {2026},
doi = {10.1002/smll.75794}
}
EUVIMED